ライフサイエンスコーパス: AV

1 AV loop placement causes serum elevations of NT-proBNP,

2 AV-101 also increased 4-Cl-KYN, 7-Cl-KYNA, 4-Cl-3-HAA, 3

3 AV-101 was safe and well tolerated.

4 AVs could increase some health risks (such as air pollut

5 AVs offer a variety of automation, vehicle ownership, an

6 rnative etiologies summarized as 38% BV, 10% AV, 5% Candida, 2% STI, 10% mixed infection (positive ta

7 We quantified in vivo retention of [F-18]-AV-1451 and performed autoradiography, [H-3]-AV-1451 bin

8 radiography failed to show detectable [F-18]-AV-1451 binding in multiple brain regions examined, with

9 The three subjects exhibited [F-18]-AV-1451 in vivo retention predominantly in basal ganglia

10 They all underwent [F-18]-AV-1451 PET imaging before death.

11 gnificant correlation between in vivo [F-18]-AV-1541 retention and postmortem in vitro binding and ta

12 18F-AV-1451 binding to the basal ganglia was strong in all g

13 18F-AV-1451 binding was increased in semantic variant primar

14 ive correlation between 11C-PK-11195 and 18F-AV-1451 uptake in all disease groups, across widespread

15 eimer's disease slices with 11C-PBB3 and 18F-AV-1451 were noted.

16 differential affinities for 11C-PBB3 and 18F-AV-1451, and higher availability of binding sites on pro

17 cipir (18F) (flortaucipir, also known as 18F-AV-1451 or 18F-T807) have made it possible to investigat

18 ndent regressions were performed between 18F-AV-1451 binding and each cognitive domain, and we used t

19 uent variant), 28 of whom underwent both 18F-AV-1451 and 11C-PK-11195 PET, and matched control subjec

20 n association between cognition and both 18F-AV-1451 uptake and grey matter volume.

21 ts of in vivo tau pathology (measured by 18F-AV-1451 PET), neuroinflammation (measured by 11C-PK11195

22 etter to clinical heterogeneity than did 18F-AV-1451: distinct spatial modes of neuroinflammation wer

23 ve to patients with Alzheimer's disease, 18F-AV-1451 binding was elevated in the midbrain (t = 2.1, P

24 line with moderate 11C-PBB3 versus faint 18F-AV-1451 autoradiographic labelling of these tissues.

25 tomography tracers such as flortaucipir (18F-AV-1451, also known as 18F-T807) have made it possible t

26 ET, and matched control subjects (14 for 18F-AV-1451 and 15 for 11C-PK-11195).

27 ed highly associated patterns of greater 18F-AV-1451 binding and increased annualized change in corti

28 rain regions was associated with greater 18F-AV-1451 PET retention most prominently in the inferior t

29 We found that: (i) 18F-AV-1451 positron emission tomography retention was diffe

30 oxy index of neuroinflammation; and (ii) 18F-AV-1451, a radioligand with increased binding to patholo

31 There was increased 18F-AV-1451 binding in multiple regions in living patients w

32 in each domain was related to increased 18F-AV-1451 binding in specific brain regions conforming to

33 showed, relative to controls, increased 18F-AV-1451 uptake in the putamen, pallidum, thalamus, midbr

34 matter volumes, and regional binding of 18F-AV-1451 and 11C-PK11195 were derived from 15 temporo-par

35 e model that included both components of 18F-AV-1451 and the first (i.e. anterior temporal) component

36 Overall, we confirm the potential of 18F-AV-1451 as a heuristic biomarker, but caution is indicat

37 elanin is an insufficient explanation of 18F-AV-1451 positron emission tomography data in vivo, at le

38 ng may contribute to disease profiles of 18F-AV-1451 positron emission tomography, especially in prim

39 rect and grey matter-mediated effects of 18F-AV-1451 uptake on cognitive performance.

40 We assessed the radiotracer 18F-AV-1451 with positron emission tomography imaging to com

41 More specifically, 18F-AV-1451 binding was significantly increased in patients

42 B) positron emission tomography and tau (18F-AV-1451) positron emission tomography, and episodic and

43 ear palsy tau deposits for 11C-PBB3 than 18F-AV-1451.

44 We suggest that 18F-AV-1451 positron emission tomography is a useful biomark

45 mortem autoradiographic data showed that 18F-AV-1451 strongly bound to Alzheimer-related tau patholog

46 We also examined the 18F-AV-1451 autoradiographic binding in post-mortem tissue f

47 palsy, and a control case to assess the 18F-AV-1451 binding specificity to Alzheimer's and non-Alzhe

48 e-associated variability; and (iii) this 18F-AV-1451 positron emission tomography retention pattern s

49 mission tomography binding antecedent to 18F-AV-1451 positron emission tomography scans, and to what

50 in florbetapir retention, antecedent to 18F-AV-1451 positron emission tomography scans, in the parie

51 the positron emission tomography tracer 18F-AV-1451) associated with well-established Alzheimer's di

52 jects underwent baseline assessment with 18F-AV-1451 PET, 11C-PK11195 PET, and structural MRI.

53 between tau pathology, as measured with 18F-AV-1451-PET imaging, and cognitive deficits in Alzheimer

54 easured by fluorine 18-labeled AV-1451 ([18F]AV-1451) positron emission tomographic (PET) imaging are

55 rongly correlated with the magnitude of [18F]AV-1451 binding (3 patients with amnesic Alzheimer disea

56 vivo evidence that distribution of the [18F]AV-1451 signal as seen on results of PET imaging is a va

57 d with the regional distribution of the [18F]AV-1451 signal.

58 Patients underwent [18F]AV-1451 PET imaging to measure tau burden, carbon 11-lab

59 An elevated [18F]-AV-1451 SUVR was associated with volumetric loss in both

60 Use of [18F]-AV-1451 has a potential for staging of the preclinical a

61 AV-1451 and performed autoradiography, [H-3]-AV-1451 binding assays, and quantitative tau measurement

62 Current questions about AVs do not now revolve around whether such technologies

63 diate arcopallium, respectively; AA, AP, AD, AV, AM, and AI).

64 tau2-18 formulated with Advax(CpG) adjuvant (AV-1980R/A) in PS19 tau transgenic mice.

65 ned in the peripheral blood before and after AV loop placement.

66 els exceeded the upper reference limit after AV loop placement, with an especially strong NT-proBNP i

67 r construct green fluorescent protein) after AV node ablation, and observed the animals for 8 weeks.

68 eregulation in blood and venous tissue after AV loop placement.

69 remodeling were determined at 8 weeks after AV-Shunt surgeries.

70 Four weeks after AV-Shunt surgery, the Cx43 mimetic peptide Gap27 or scra

71 autophagy induction, suggesting that altered AV biogenesis is part of the pathological features of th

72 ebo gel was locally delivered to group 1 and AV gel to group 2.

73 AV-1953R, or the combination of AV-1959R and AV-1980R vaccines formulated with Advax(CpG) induced rob

74 tological findings in goat models for AF and AV block (AVB) using JavaCyte.

75 Atropine abolished the bradycardia and AV block, but the atropine-insensitive tachycardia and P

76 e was similarly increased in both MI-CHF and AV-CHF rats compared to control.

77 the peptide tertiapin-Q could improve HR and AV conduction in these mouse strains.

78 sitron emission tomography ligands, PBB3 and AV-1451, by fluorescence, autoradiography and homogenate

79 of non-ghost and ghost tangles with PBB3 and AV-1451, while dystrophic neurites were more clearly det

80 state (peroxide and anisidine value, PV and AV) required for refined oils.

81 sed only in MI-CHF rats compared to Sham and AV-CHF rats.

82 tein responsible for maintaining appropriate AV node conduction through maintaining gap junction prot

83 Arteriovenous (AV) fistulas for hemodialysis can lead to cardiac volume

84 ed vascular heterogeneity and arteriovenous (AV) shunting, which results in tumor hypoxia and inadequ

85 niques to detect and quantify arteriovenous (AV) shunting and tumor hypoxia in patients with GBM.

86 A side-to-side arteriovenous (AV) shunt was created between the distal stump of one of

87 ional flortaucipir F 18 (previously known as AV 1451, T807) positron emission tomography (FTP-PET) im

88 In pigs with complete atrioventricular (AV) block, transcription factor T-box 18 (TBX18) was inj

89 d by atrial tachycardia or atrioventricular (AV) block.

90 rate faster than the slow atrioventricular (AV) junctional escape rhythm observed in control CAVB an

91 longitudinal motion of the atrioventricular (AV) plane.

92 nduced loss of ZO-1 led to atrioventricular (AV) block without changes in heart rate, as measured by

93 e, auditory enhancement of visual attention (AV) and visual enhancement of auditory speech (VA).

94 stem (T3SS) is a well-studied and attractive AV target, given that it is widespread in more than 25 s

95 Audiovisual (AV) integration is essential for speech comprehension, e

96 In this study, we examined audiovisual (AV) processing in normal and visually impaired individua

97 dchild (GP) pairs, 80.0%-97.5% of avuncular (AV) pairs, and 75.5%-98.5% of half-siblings (HS) pairs c

98 significant distances were detected between AV/RG and the most genetically different RE breed, using

99 identified differentiating patterns between AV, BV, and Lactobacillus-dominated vaginal microbiomes.

100 were comparable following TAVR for bicuspid AV versus tricuspid AV disease.

101 c insufficiency among patients with bicuspid AV (2.7% versus 2.1%; P<0.001).

102 treatment option for patients with bicuspid AV disease.

103 e outcomes of TAVR in patients with bicuspid AV stenosis in comparison with those with tricuspid AV s

104 99]) was observed for patients with bicuspid AV versus patients with tricuspid AV in the Medicare-lin

105 ith tricuspid valves, patients with bicuspid AV were younger and had a lower Society of Thoracic Surg

106 es were used to treat patients with bicuspid AV, device success increased (93.5 versus 96.3; P=0.001)

107 2%) were performed in patients with bicuspid AV, including 3705 with current-generation devices.

108 s evoked complex brady-tachycardia with both AV block and premature ventricular contractions (PVCs).

109 ides act on purinoceptors on cardiomyocytes, AV and SA nodes, cardiac fibroblasts, and coronary blood

110 e significantly reduced; 2) apoptotic CD4(+)/AV(+)/CEACAM-1(+) and CD8(+)/AV(+)/CEACAM-1(+) T lymphoc

111 poptotic CD4(+)/AV(+)/CEACAM-1(+) and CD8(+)/AV(+)/CEACAM-1(+) T lymphocytes were significantly reduc

112 n RV PICM was evident 4 weeks after complete AV block in both groups; subsequent intervention led to

113 AVN) region of adult rats to create complete AV block.

114 ses, including atrial fibrillation, complete AV block, heart failure and supraventricular tachycardia

115 In addition, under non-denaturing conditions AV-1980R/A sera preferentially recognized AD-associated

116 other RCC subtypes are aorta-based corrected AV and aorta-based corrected relative contrast enhanceme

117 9-95 HU and renal parenchyma-based corrected AV of 87-95 HU showed a diagnostic accuracy of 81-86%, 8

118 ut-off AV of 86-89 HU, aorta-based corrected AV of 89-95 HU and renal parenchyma-based corrected AV o

119 cin/vincristine/prednisone/cyclophosphamide (AV-PC).

120 Tjp1 (Tjp1(fl/fl); Hcn4(CreERt2)) developed AV block while tamoxifen-induced conduction system delet

121 lation at presynaptic terminals by enhancing AV retrograde transport.

122 Conclusion:(18)F-AV-133 had substantial management impact in patients wit

123 tion 2 h after injection of 250 MBq of (18)F-AV-133, and the resulting images were quantitatively ass

124 ges were calculated from 80-100 minute (18)F-AV-1451 (also known as T807) positron emission tomograph

125 erent strategies for quantification of (18)F-AV-1451 (T807) tau binding, including models with blood

126 l syndrome) underwent 180-min PET with (18)F-AV-1451 and arterial blood sampling.

127 l syndrome) underwent 180-min PET with (18)F-AV-1451 and arterial blood sampling.

128 R30-150 < 1.5), and for ROIs with high (18)F-AV-1451 binding (hROIs, mean of BPND + 1 and DVR30-150 >

129 in), for all values, for ROIs with low (18)F-AV-1451 binding (lROIs, mean of BPND + 1 and DVR30-150 <

130 bjective of this study was to evaluate (18)F-AV-1451 binding with full kinetic analysis using a metab

131 (18)F-AV-1451 deposition was greatest in the 2 nodes of the sy

132 Quantitative region-based analysis of (18)F-AV-1451 images yielded region of interest and voxel leve

133 the novel tau-specific PET radioligand (18)F-AV-1451 in cognitively healthy control (HC) and Alzheime

134 (18)F-AV-1451 is currently the most widely used of several exp

135 Methods:(18)F-AV-1451 PET brain imaging was completed in 16 4 young he

136 (18)F-AV-1451 PET imaging was performed on 43 subjects (5 youn

137 - and sex-matched control subjects had (18)F-AV-1451 positron emission tomography using a Siemens hig

138 AD demonstrated increased (18)F-AV-1451 retention compared with YHV and AHV based on bot

139 displayed visually apparent decreased (18)F-AV-1451 signal in the midbrain.

140 Our data suggest that although (18)F-AV-1451 SUVR curves do not reach a plateau and are still

141 +/- 7.0 y; 4 women) were scanned with (18)F-AV-1451 tau PET to determine tau deposition in the brain

142 hether (18)F-flortaucipir (also called (18)F-AV-1451) PET, targeting tau aggregates, detects these di

143 e not able to describe the kinetics of (18)F-AV-1451, with poor fits in 33%-53% of cortical regions a

144 ssion tomography (PET) tracer known as (18)F-AV-1451; and (2) amyloid-beta, quantified with (11)C-PiB

145 Mean (18)F-FDG uptake and mean (18)F-AV-45 SUV ratio (SUVr) in regions of hypometabolism and

146 Mean (18)F-FDG uptake and mean (18)F-AV-45 SUVr in AD-typical regions were also significantly

147 d 0.90 for mean (18)F-FDG uptake, mean (18)F-AV-45 SUVr, and their combination (n = 22), respectively

148 distributions of [(11) C]PK11195 and [(18) F]AV-1451 binding were determined by principal component a

149 Regional [(11) C]PK11195 and [(18) F]AV-1451 binding were positively correlated (R = 0.577, p

150 The [(11) C]PK11195 and [(18) F]AV-1451 BP(ND) values were correlated across all regions

151 ciations between [(11) C]PK11195 and [(18) F]AV-1451 components' loadings were found in both subcorti

152 flammation using [(11) C]PK11195 and [(18) F]AV-1451 PET in 17 patients with progressive supranuclear

153 We used [(18)F]AV-1451 and [(11)C]PiB positron emission tomography, str

154 ions had a consistent distribution of [(18)F]AV-1451 binding across the brain, with heterogeneous dis

155 nalysis, based on the distribution of [(18)F]AV-1451 binding potential, separated semantic dementia f

156 [(18)F]AV-1451 binds in vivo regions that are likely to contain

157 ll be useful to assess the utility of [(18)F]AV-1451 to differentiate and track different types of fr

158 oposed 'off target' binding sites for [(18)F]AV-1451, such as neuronal monoamine oxidase or neuromela

159 le this suggests a non-tau target for [(18)F]AV-1451, the pathological regions in semantic dementia d

160 vo binding of the putative tau ligand [(18)F]AV-1451, which is elevated in frontotemporal lobar degen

161 mission tomography brain imaging with [(18)F]AV-1451.

162 hology, indexed using the radioligand [(18)F]AV-1451.

163 The first AV fleets are already in service in US cities.

164 antify MH, fluorine 18 ((18)F) flortaucipir (AV-1451) PET was performed to quantify tau, and (18)F-fl

165 ons within a winner-take-all neural code for AV timing might exaggerate responses, such that evoked r

166 We performed esophagogastroduodenoscopy for AV visualization in 102 > 18 years old using FVE followe

167 The mean time of duodenal examination for AV visualization was lower on CAE compared to FVE (1.41

168 The complete visualization rate for AV was higher in CAE (97.0%) compared to FVE (51.0%) (p

169 ggesting ZO-1 is differentially required for AV node and ventricular conduction.

170 and low KYNA, is also a potential target for AV-101.

171 od was correlated with miRNA expression from AV loop vascular tissue.

172 Furthermore, AV-Shunt(Gap27) showed less cardiac arrhythmogenesis and

173 The effect of Aloe vera gel (AV) and Aloe arborescens gel (AA) alone or in combinatio

174 Patients with probable DLB had greater AV-1451 uptake in the posterior temporoparietal and occi

175 Defining the algorithms that will help AVs make these moral decisions is a formidable challenge

176 e AD dementia group had significantly higher AV-1451 uptake than the probable DLB group, and medial t

177 at ZO-1 is abundantly expressed in the human AV node and colocalizes with Cx40.

178 Center underwent magnetic resonance imaging, AV-1451, and Pittsburgh compound-B (PiB) PET examination

179 on in regulating the expression of NaV1.5 in AV node.

180 sodium channel protein NaV1.5 was altered in AV nodal cells of the ZO-1cKO versus CTL.

181 reduced in the CBs of MI-CHF rats but not in AV-CHF rats.

182 resting aortic valve (AV) gradient, indexed AV area, METs, and heart rate recovery were 2.9+/-3%, 58

183 INTERPRETATION: AV-1451 may have limited utility for in vivo selective a

184 nts (66%) underwent AV surgery (36% isolated AV surgery, 16% concomitant coronary bypass, and 58% aor

185 operative mortality was 2% (0.6% in isolated AV surgery).

186 gic findings measured by fluorine 18-labeled AV-1451 ([18F]AV-1451) positron emission tomographic (PE

187 at evaluating synchrony of auditory-leading (AV) versus visual-leading (VA) audiovisual stimulus pair

188 INTERPRETATION: Medial temporal lobe AV-1451 uptake distinguishes AD dementia from probable D

189 rdiovascular disease was evident from a mean AV gradient >20.0 mm Hg (moderate AS) after adjusting fo

190 rroborate brain target engagement of 1440 mg AV-101 in humans, consistent with blockade of interneuro

191 Linear mixed models revealed that 1440 mg AV-101, but not 720 mg, increased 40 Hz ASSR and 40 Hz A

192 de, were administered via osmotic minipumps (AV-Shunt(Gap27) or AV-Shunt(Scr)) for 4 weeks.

193 load using the arterio-venous fistula model (AV-Shunt) in adult male rats.

194 odel (MI-CHF) and as a high output HF model (AV-CHF), respectively.

195 The KP modulator AV-101 (4-chlorokynurenine, 4-Cl-KYN), an oral prodrug o

196 trast, HSulf-1 proficient cells exhibit more AVs and reduced LDs.

197 gration of unimodal (A or V) and multimodal (AV) sensory cues.

198 ated posterior temporoparietal and occipital AV-1451 uptake in probable DLB and its association with

199 s rates of 38.5%-76.0% of GP, 60.5%-92.0% of AV, 73.0%-95.0% of HS pairs.

200 relationship types for 93.5% of GP, 97.7% of AV, and 92.2% of HS pairs that have sufficient mutual re

201 Western blot and immunostaining analyses of AV nodes showed that ZO-1 loss decreased Cx (connexin) 4

202 the temporal and spatial characteristics of AV processing and assess differences in neural responses

203 ope vaccine, AV-1953R, or the combination of AV-1959R and AV-1980R vaccines formulated with Advax(CpG

204 ter isolating the multisensory components of AV-VA event-related potentials (ERPs) from the sum of th

205 networks learned from a clinical dataset of AV-45 PET image and compare network properties of both u

206 ary SND associated with different degrees of AV block.

207 Future studies should test higher doses of AV-101 in depression.

208 elists did not detect any negative effect of AV gel and FI plant extract on the sensory attributes of

209 ver study to examine dose-related effects of AV-101 (720 and 1440 mg) on NMDAR engagement measured by

210 and visual cortices, as opposed to fusion of AV percepts in a multisensory integrator.

211 in no change Cx43 expression in the heart of AV-Shunt rats.

212 showed slower and less accurate judgments of AV and V stimuli but more accurate responses in the A-al

213 Measurement of AV integration was accomplished via quantification of th

214 Healthy models of AV use include fully electric vehicles in a system of ri

215 ms contribute to the efficient processing of AV speech in background noise.

216 recent placebo-controlled clinical trial of AV-101 in depression found negative results.

217 mpare the rates of complete visualization of AV using this cap-assisted endoscopy (CAE) approach to s

218 lemented before the complete introduction of AVs into the market.

219 he number of LDs and increased the number of AVs compared to vector controls.

220 The overall rate of AVs across the 5 specialties was 81.2%; the highest rate

221 ing ccRCC from other RCC subtypes, a cut-off AV of 86-89 HU, aorta-based corrected AV of 89-95 HU and

222 s /ba/ and /fa/, presented in Auditory-only, AV congruent or incongruent contexts.

223 FI 1% added to AV 50% or AV 100% efficiently maintained higher ascorbic acid, tot

224 ed via osmotic minipumps (AV-Shunt(Gap27) or AV-Shunt(Scr)) for 4 weeks.

225 ) and severe AS (>=40.0 mm Hg, >=4.0 m/s, or AV area <1.0 cm(2) in low-flow, low-gradient severe AS).

226 complications than eyes with partial PPVs or AVs during the average 4 years of follow-up.

227 who underwent total PPVs and partial PPVs or AVs.

228 All fish oils complied with a p-AV limit of 30, 98% with a PV limit of 10 meq O2/kg, and

229 Peroxide Value (PV), para-Anisidine Value (p-AV), and TOTOX, respectively.

230 FLAIR and gradient recall echo MRI, tau-PET (AV-1451) and amyloid-PET scans were identified.

231 tive, 3/4 of the latter samples had positive AV targets with one also was STI positive.

232 ne the correlation of in vivo and postmortem AV-1451 binding patterns in three autopsy-confirmed non-

233 T790, generalized to patient-derived primary AV cells and was sufficient to prevent and treat AV dise

234 p.R438H) within endocardium causes a reduced AV valve area, a downregulation of Wnt/B-catenin signall

235 ts show that IRD individuals exhibit reduced AV integration for concurrent audio and visual (AV) stim

236 sedentarism); however, if proper regulated, AVs will likely reduce morbidity and mortality from moto

237 Whether short-term AV loop placement in patients undergoing microsurgery ha

238 Building upon this idea, we proposed that AV integration in spoken language reflects visually indu

239 The AV-1980R/A induced extremely high antibody responses and

240 egulation of Wnt/B-catenin signalling at the AV canal, and growth of additional tissue mass in adult

241 eal data to index the similarity between the AV and VA maps at each time point (500 ms window after s

242 nal similarity analysis (tRSA) comparing the AV and VA ERP maps.

243 ory manner but was still not detected in the AV nodal myocytes.

244 uction system deletion of Tjp1 distal to the AV node (Tjp1(fl/fl); Kcne1(CreERt2)) did not demonstrat

245 r separate neuronal mechanisms underlie this AV-VA dichotomy in humans.

246 FI 1% added to AV 50% or AV 100% efficiently maintained higher ascorbic

247 in 34 FVE and 24 CAE, with no association to AV complete visualization rates (p = 0.30 and p = 0.14).

248 ate distinct selectivity of PBB3 compared to AV-1451 for diverse tau fibril strains.

249 ced hypoxic ventilatory response compared to AV-CHF rats.

250 is and cardiac hypertrophy index compared to AV-Shunt(Scr).

251 s with less than a complete response (CR) to AV-PC received 21-Gy involved-field radiation therapy (I

252 erefore, the addition of FI plant extract to AV gel coating could be a promising approach to prolong

253 at positron emission tomography (PET) tracer AV-1451 exhibits high binding affinity for paired helica

254 ositron emission tomography (PET) tau tracer AV-1451 uptake in patients with probable DLB, compared t

255 rom the pivotal evaluations of transcatheter AV replacement (TAVR) devices.

256 ells and was sufficient to prevent and treat AV disease in vivo in a mouse model.

257 lowing TAVR for bicuspid AV versus tricuspid AV disease.

258 h bicuspid AV versus patients with tricuspid AV in the Medicare-linked cohort, whereas no difference

259 osis in comparison with those with tricuspid AV stenosis.

260 tly lower in the bicuspid (versus tricuspid) AV group (96.3% in bicuspid versus 97.4% in tricuspid, P

261 to explain the neural mechanisms underlying AV integration.

262 Over 6.9+/-3 years, 341 (64%) underwent AV replacement (54% isolated), and there were 104 (20%)

263 .6 +/- 3 years, 933 patients (66%) underwent AV surgery (36% isolated AV surgery, 16% concomitant cor

264 Fifteen patients underwent AV loop placement with delayed free flap anastomosis for

265 In protocol B, PICM was established by using AV node ablation and 4 weeks of electronic RV pacing, at

266 The expression of TIM-3 and annexin V (AV) as well as the production of IFN-gamma and the intra

267 The dual-epitope vaccine, AV-1953R, or the combination of AV-1959R and AV-1980R va

268 droplets (LDs), reduced autophagic vacuoles (AVs) and less LC3B puncta.

269 of transporting nascent autophagic vacuoles (AVs) from distal axons toward the soma, where mature lys

270 ay, including testing for aerobic vaginitis (AV), Candida, sexually transmitted infections (STI), and

271 nish bovine breeds (Asturiana de los Valles, AV; Retinta, RE; and Rubia Gallega, RG) were estimated f

272 id contents were increased while acid value (AV), peroxide value (PV) and color values were decreased

273 evaluated in terms of CT attenuation values (AV) and differences in contrast density; the aorta or re

274 jection fraction, mean resting aortic valve (AV) gradient, indexed AV area, METs, and heart rate reco

275 2 +/- 19 years), with measured aortic valve (AV) mean gradient, peak velocity, and/or area.

276 Patients with bicuspid aortic valve (AV) stenosis were excluded from the pivotal evaluations

277 of heart disease involving the aortic valve (AV).

278 simultaneity judgment task including various AV-VA asynchronies and unisensory control conditions (vi

279 cation for visualizing the ampulla of Vater (AV) involves attaching a cap to the tip of the forward-v

280 Automated vehicles (AVs) already navigate US highways and those of many othe

281 Autonomous vehicles (AVs) have the potential to shape urban life and signific

282 ium anterius (AA), the arcopallium ventrale (AV), the arcopallium dorsale (AD), the arcopallium inter

283 nsitive bradycardia with atrial-ventricular (AV) block in conscious WKY rats, thus indicating a paras

284 The effect of Aloe vera (AV) gel (at 50% or 100%) alone or enriched with Fagonia

285 activation also induces autophagic vesicle (AV) biogenesis through the generation of phosphatidylino

286 ntella asiatica (CA) and Amaranthus viridis (AV) extracts and investigate their respective antioxidan

287 Anti-virulence (AV) compounds are a promising alternative to traditional

288 P) and a 31% decrease in apparent viscosity (AV) at 150 degrees C under 70 MPa pressure, as compared

289 was assessed by the rate of avoided visits (AVs), defined by the absence of an in-person visit to th

290 integration for concurrent audio and visual (AV) stimuli but increased brain activity during the unim

291 We examined this using audio-visual (AV) timing and confidence judgments, in conjunction with

292 nding on the leading input: auditory-visual (AV) or visual-auditory (VA).

293 o had partial PPVs or anterior vitrectomies (AVs) at the time of KPro implantation (n = 26).

294 y PBB3 fluorescence in contrast to very weak AV-1451 signals.

295 At 8(th) week, AV-Shunt(Gap27) showed a marked decrease in the progress

296 This raises the question of whether AV-101 can penetrate the brain and engage the NMDAR and

297 sual-only, auditory-only) and tested whether AV and VA processing generate different patterns of brai

298 t predominantly targeting misfolded tau with AV-1980R/A could represent an effective strategy for AD

299 Sapodilla fruit treated with AV 100% and FI 1% significantly reduced weight loss, dec

300 myloid-beta (Abeta) oligomers associate with AVs in AD axons and interact with dynein motors.